Communiqués Oramed Pharmaceuticals Inc.

Actions

ORMP

US68403P2039

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX Autres places de cotation 21:46:05 11/08/2026			Varia. 5j.	Varia. 1 janv.
4,280 ^USD	+1,90%		-3,81%	+50,53%

10/08	Oramed Pharmaceuticals Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
19/05	Oramed Pharmaceuticals Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

10/08	Oramed: Q2 Earnings Snapshot	AQ
25/06	Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet	PR
17/06	Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes	PR
19/05	Oramed: Q1 Earnings Snapshot	AQ
26/03	Oramed: Q4 Earnings Snapshot	AQ
13/11	Oramed: Q3 Earnings Snapshot	AQ
15/08/25	Oramed: Q2 Earnings Snapshot	AQ
16/05/25	Oramed: Q1 Earnings Snapshot	AQ
28/04/25	Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals	AQ
12/02/25	Oramed Pharmaceuticals : Ancillary Agreement Completion Protocol and Supplemental Agreement	PU
18/12/24	Oramed Pharmaceuticals : Reception of an additional payment from Scilex Holding Company	PU
10/11/24	Oramed Pharmaceuticals : INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTSAS OF SEPTEMBER 30, 2024	PU
30/10/24	Oramed Pharmaceuticals : Other Report or Announcement	PU
08/10/24	Oramed Pharmaceuticals : Announces Restructuring of Scilex Holding Company Debt Form 8 K	PU
15/08/24	Oramed: Q2 Earnings Snapshot	AQ
02/08/24	Oramed Pharmaceuticals : Submission of Matters to a Vote of Security Holders Form 8 K	PU
26/06/24	Oramed Pharmaceuticals : The Company’s Board of Directors authorized a stock buyback program to purchase up to $20,000,000	PU
24/06/24	Oramed Pharmaceuticals : Received an additional payment from Scilex	PU
20/06/24	ORAMED PHARMACEUTICALS : 2023 ANNUAL REPORT	PU
20/06/24	Oramed Pharmaceuticals : PROXY STATEMENT OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 1, 2024	PU
13/05/24	Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	PU
10/05/24	Oramed: Q1 Earnings Snapshot	AQ
06/05/24	Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	PU
26/03/24	Oramed Pharmaceuticals : 13D-Nadav Kidron	PU
19/03/24	Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	PU